Published in Antimicrob Agents Chemother on October 01, 1997
Rapid detection of Mycobacterium tuberculosis and rifampin resistance by use of on-demand, near-patient technology. J Clin Microbiol (2009) 12.98
Use of the genotype MTBDR assay for rapid detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis complex isolates. J Clin Microbiol (2005) 3.61
Genotypic analysis of Mycobacterium tuberculosis in two distinct populations using molecular beacons: implications for rapid susceptibility testing. Antimicrob Agents Chemother (2000) 3.56
A commercial line probe assay for the rapid detection of rifampicin resistance in Mycobacterium tuberculosis: a systematic review and meta-analysis. BMC Infect Dis (2005) 3.05
Spread of drug-resistant Mycobacterium tuberculosis strains of the Beijing genotype in the Archangel Oblast, Russia. J Clin Microbiol (2002) 2.92
Use of genotype MTBDR assay for molecular detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis clinical strains isolated in Italy. J Clin Microbiol (2006) 2.61
Mutations in the rpoB gene of rifampin-resistant Mycobacterium tuberculosis strains isolated mostly in Asian countries and their rapid detection by line probe assay. J Clin Microbiol (1999) 2.46
Comparison of two commercially available DNA line probe assays for detection of multidrug-resistant Mycobacterium tuberculosis. J Clin Microbiol (2006) 2.41
Rapid and inexpensive drug susceptibility testing of Mycobacterium tuberculosis with a nitrate reductase assay. J Clin Microbiol (2002) 2.36
Relevance of commercial amplification methods for direct detection of Mycobacterium tuberculosis complex in clinical samples. J Clin Microbiol (2003) 2.32
Molecular detection of antimicrobial resistance. Clin Microbiol Rev (2001) 2.31
Molecular characterization of rifampin-resistant isolates of Mycobacterium tuberculosis from Hungary by DNA sequencing and the line probe assay. J Clin Microbiol (2001) 2.21
Characterization of rpoB mutations in rifampin-resistant clinical isolates of Mycobacterium tuberculosis from Turkey by DNA sequencing and line probe assay. J Clin Microbiol (2002) 1.96
Multidrug-resistant tuberculosis in prison inmates, Azerbaijan. Emerg Infect Dis (2001) 1.75
Evaluation of the Genotype MTBDR assay for rapid detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis isolates. J Clin Microbiol (2006) 1.63
Genetic methods for assessing antimicrobial resistance. Antimicrob Agents Chemother (1999) 1.60
Modern laboratory diagnosis of mycobacterial infections. J Clin Pathol (2000) 1.56
Direct detection of multidrug-resistant Mycobacterium tuberculosis in clinical specimens in low- and high-incidence countries by line probe assay. J Clin Microbiol (2003) 1.54
Newly developed primers for comprehensive amplification of the rpoB gene and detection of rifampin resistance in Mycobacterium tuberculosis. J Clin Microbiol (2006) 1.45
Mutations in the rpoB and katG genes leading to drug resistance in Mycobacterium tuberculosis in Latvia. J Clin Microbiol (2002) 1.35
Direct detection of Mycobacterium tuberculosis complex DNA and rifampin resistance in clinical specimens from tuberculosis patients by line probe assay. J Clin Microbiol (2006) 1.34
Rapid colorimetric method for testing susceptibility of Mycobacterium tuberculosis to isoniazid and rifampin in liquid cultures. J Clin Microbiol (2003) 1.31
Identification of rifampin-resistant Mycobacterium tuberculosis strains by hybridization, PCR, and ligase detection reaction on oligonucleotide microchips. J Clin Microbiol (2001) 1.31
Management of newborn infant born to mother suffering from tuberculosis: current recommendations & gaps in knowledge. Indian J Med Res (2014) 1.29
Multidrug-resistant tuberculosis detection, Latvia. Emerg Infect Dis (2005) 1.28
Evaluation of a new line probe assay for rapid identification of gyrA mutations in Mycobacterium tuberculosis. Antimicrob Agents Chemother (2005) 1.23
Development and evaluation of a line probe assay for rapid identification of pncA mutations in pyrazinamide-resistant mycobacterium tuberculosis strains. J Clin Microbiol (2007) 1.22
Fluorometric assay for testing rifampin susceptibility of Mycobacterium tuberculosis complex. J Clin Microbiol (2008) 1.13
Detection of rifampin resistance in Mycobacterium tuberculosis by double gradient-denaturing gradient gel electrophoresis. Antimicrob Agents Chemother (1999) 1.08
Detection of mutations associated with isoniazid and rifampin resistance in Mycobacterium tuberculosis isolates from Samara Region, Russian Federation. J Clin Microbiol (2004) 1.07
High frequency of mutations in the rpoB gene in rifampin-resistant clinical isolates of Mycobacterium tuberculosis from Singapore. J Clin Microbiol (2005) 1.02
Mycobacterium tuberculosis and rifampin resistance, United Kingdom. Emerg Infect Dis (2006) 1.02
Rapid detection of rpoB gene mutations conferring rifampin resistance in Mycobacterium tuberculosis. J Clin Microbiol (2012) 1.02
Development of multiplex assay for rapid characterization of Mycobacterium tuberculosis. J Clin Microbiol (2007) 0.99
Identification of katG mutations associated with high-level isoniazid resistance in Mycobacterium tuberculosis. Antimicrob Agents Chemother (2010) 0.99
Multidrug-resistant tuberculosis in Ethiopia: efforts to expand diagnostic services, treatment and care. Antimicrob Resist Infect Control (2014) 0.99
Multidrug-resistant tuberculosis drug susceptibility and molecular diagnostic testing. Am J Med Sci (2013) 0.90
Implementation validation performed in Rwanda to determine whether the INNO-LiPA Rif.TB line probe assay can be used for detection of multidrug-resistant Mycobacterium tuberculosis in low-resource countries. J Clin Microbiol (2007) 0.90
Comprehensive multicenter evaluation of a new line probe assay kit for identification of Mycobacterium species and detection of drug-resistant Mycobacterium tuberculosis. J Clin Microbiol (2012) 0.89
Anti tuberculosis drug resistance in west of iran. J Glob Infect Dis (2014) 0.88
Bacterial nanoscale cultures for phenotypic multiplexed antibiotic susceptibility testing. J Clin Microbiol (2014) 0.86
A microbiological revolution meets an ancient disease: improving the management of tuberculosis with genomics. Clin Microbiol Rev (2015) 0.86
Evaluation of the AID TB resistance line probe assay for rapid detection of genetic alterations associated with drug resistance in Mycobacterium tuberculosis strains. J Clin Microbiol (2014) 0.83
Characterization of Tunisian Mycobacterium tuberculosis rifampin-resistant clinical isolates. J Clin Microbiol (2007) 0.80
Pyrosequencing for rapid detection of tuberculosis resistance in clinical isolates and sputum samples from re-treatment pulmonary tuberculosis patients. BMC Infect Dis (2014) 0.79
Evolution of central nervous system multidrug-resistant Mycobacterium tuberculosis and late relapse of cryptic prosthetic hip joint tuberculosis: complications during treatment of disseminated isoniazid-resistant tuberculosis in an immunocompromised host. J Clin Microbiol (2008) 0.77
Highly multiplexed, ten-color detection of isoniazid, fluoroquinolone, amikacin and kanamycin resistant tuberculosis in an automated assay suitable for point-of-care use. J Clin Microbiol (2016) 0.76
Evaluation of the performance of nitrate reductase assay for rapid drug-susceptibility testing of mycobacterium tuberculosis in north India. J Health Popul Nutr (2011) 0.76
Clonal expansion of Mycobacterium tuberculosis isolates and coexisting drug resistance in patients newly diagnosed with pulmonary tuberculosis in Hanoi, Vietnam. BMC Res Notes (2013) 0.76
Validation of a real-time PCR assay for the molecular identification of Mycobacterium tuberculosis. Braz J Microbiol (2015) 0.75
General and advanced diagnostic tools to detect Mycobacterium tuberculosis and their drug susceptibility: a review. Eur J Clin Microbiol Infect Dis (2015) 0.75
Rapid Sputum Multiplex Detection of the M. tuberculosis Complex (MTBC) and Resistance Mutations for Eight Antibiotics by Nucleotide MALDI-TOF MS. Sci Rep (2017) 0.75
Detection of drug resistance in Mycobacterium tuberculosis. Germs (2016) 0.75
Rapid and simple method for purification of nucleic acids. J Clin Microbiol (1990) 44.73
Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis. Lancet (1993) 16.75
The emergence of drug-resistant tuberculosis in New York City. N Engl J Med (1993) 12.71
Advances in techniques of testing mycobacterial drug sensitivity, and the use of sensitivity tests in tuberculosis control programmes. Bull World Health Organ (1969) 12.55
Implications of multidrug resistance for the future of short-course chemotherapy of tuberculosis: a molecular study. Lancet (1994) 9.20
Genetic analysis of amplified DNA with immobilized sequence-specific oligonucleotide probes. Proc Natl Acad Sci U S A (1989) 7.79
Characterization by automated DNA sequencing of mutations in the gene (rpoB) encoding the RNA polymerase beta subunit in rifampin-resistant Mycobacterium tuberculosis strains from New York City and Texas. J Clin Microbiol (1994) 6.91
Characterization of rifampin-resistance in pathogenic mycobacteria. Antimicrob Agents Chemother (1994) 5.64
Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assay. J Gen Virol (1993) 5.26
Direct, automated detection of rifampin-resistant Mycobacterium tuberculosis by polymerase chain reaction and single-strand conformation polymorphism analysis. Antimicrob Agents Chemother (1993) 4.54
Molecular mechanisms of multiple drug resistance in clinical isolates of Mycobacterium tuberculosis. J Infect Dis (1995) 4.12
Rapid detection of rifampicin resistance in sputum and biopsy specimens from tuberculosis patients by PCR and line probe assay. Tuber Lung Dis (1995) 3.83
Relationship between rifampin MICs for and rpoB mutations of Mycobacterium tuberculosis strains isolated in Japan. Antimicrob Agents Chemother (1996) 3.82
Rifampicin resistance and mutation of the rpoB gene in Mycobacterium tuberculosis. FEMS Microbiol Lett (1996) 3.40
Quality assurance programme for drug susceptibility testing of Mycobacterium tuberculosis in the WHO/IUATLD Supranational Laboratory Network: first round of proficiency testing. Int J Tuberc Lung Dis (1997) 3.37
Qualitative and quantitative drug-susceptibility tests in mycobacteriology. Am Rev Respir Dis (1988) 3.11
Evaluation of a line probe assay kit for characterization of rpoB mutations in rifampin-resistant Mycobacterium tuberculosis isolates from New York City. J Clin Microbiol (1997) 2.81
Tuberculosis symposium: emerging problems and promise. J Infect Dis (1993) 2.55
Genotypic detection of Mycobacterium tuberculosis rifampin resistance: comparison of single-strand conformation polymorphism and dideoxy fingerprinting. J Clin Microbiol (1995) 2.26
Direct genotypic detection of Mycobacterium tuberculosis rifampin resistance in clinical specimens by using single-tube heminested PCR. J Clin Microbiol (1995) 2.08
Multidrug-resistant tuberculosis and its control. Res Microbiol (1993) 2.02
Mutations in the rpoB gene of Mycobacterium tuberculosis that interfere with PCR-single-strand conformation polymorphism analysis for rifampin susceptibility testing. J Clin Microbiol (1997) 1.89
Detection of a genetic locus encoding resistance to rifampin in mycobacterial cultures and in clinical specimens. Diagn Microbiol Infect Dis (1994) 1.81
Evolution of rifampin resistance in human immunodeficiency virus-associated tuberculosis. Am J Respir Crit Care Med (1995) 1.25
Antituberculosis drug resistance: is it worth measuring? The WHO/IUATLD Working Group on Antituberculosis Drug Resistance Surveillance. Monaldi Arch Chest Dis (1996) 0.94
Predominance of a single genotype of Mycobacterium tuberculosis in countries of east Asia. J Clin Microbiol (1995) 15.19
Compilation of small ribosomal subunit RNA structures. Nucleic Acids Res (1993) 11.07
The European Large Subunit Ribosomal RNA Database. Nucleic Acids Res (2001) 7.61
Analysis of the population structure of Mycobacterium tuberculosis in Ethiopia, Tunisia, and The Netherlands: usefulness of DNA typing for global tuberculosis epidemiology. J Infect Dis (1995) 6.95
Characterization of rifampin-resistance in pathogenic mycobacteria. Antimicrob Agents Chemother (1994) 5.64
Spectrum of immunodeficiency in HIV-1-infected patients with pulmonary tuberculosis in Zaire. Lancet (1993) 5.52
A novel pathogenic taxon of the Mycobacterium tuberculosis complex, Canetti: characterization of an exceptional isolate from Africa. Int J Syst Bacteriol (1997) 5.28
Compilation of small ribosomal subunit RNA sequences. Nucleic Acids Res (1991) 5.03
Diagnosis of Mycobacterium microti infections among humans by using novel genetic markers. J Clin Microbiol (1998) 4.83
Insects in the transmission of Mycobacterium ulcerans infection. Lancet (1999) 4.46
Rapid detection of rifampicin resistance in sputum and biopsy specimens from tuberculosis patients by PCR and line probe assay. Tuber Lung Dis (1995) 3.83
Proposed minimal standards for the genus Mycobacterium and for description of new slowly growing Mycobacterium species. Int J Syst Bacteriol (1992) 3.65
Identification of Mycobacterium species by using amplified ribosomal DNA restriction analysis. J Clin Microbiol (1993) 3.38
Pulmonary tuberculosis in HIV-infected patients in Zaire. A controlled trial of treatment for either 6 or 12 months. N Engl J Med (1995) 3.09
Inadequacy of the current WHO re-treatment regimen in a central Siberian prison: treatment failure and MDR-TB. Int J Tuberc Lung Dis (1999) 3.08
Database on the structure of small ribosomal subunit RNA. Nucleic Acids Res (1997) 2.95
DNA probes demonstrate a single highly conserved strain of Mycobacterium avium infecting AIDS patients. Lancet (1989) 2.91
Typing of Helicobacter pylori vacA gene and detection of cagA gene by PCR and reverse hybridization. J Clin Microbiol (1998) 2.77
Detection of rifampicin resistance in Mycobacterium tuberculosis isolates from diverse countries by a commercial line probe assay as an initial indicator of multidrug resistance. Int J Tuberc Lung Dis (2000) 2.71
IS901, a new member of a widespread class of atypical insertion sequences, is associated with pathogenicity in Mycobacterium avium. Mol Microbiol (1991) 2.64
Database on the structure of small ribosomal subunit RNA. Nucleic Acids Res (1996) 2.59
Comparative analysis of more than 3000 sequences reveals the existence of two pseudoknots in area V4 of eukaryotic small subunit ribosomal RNA. Nucleic Acids Res (2000) 2.56
Direct detection and identification of Mycobacterium ulcerans in clinical specimens by PCR and oligonucleotide-specific capture plate hybridization. J Clin Microbiol (1997) 2.50
A simple PCR method for rapid genotype analysis of Mycobacterium ulcerans. J Clin Microbiol (2000) 2.43
The European small subunit ribosomal RNA database. Nucleic Acids Res (2000) 2.43
Database on the structure of small ribosomal subunit RNA. Nucleic Acids Res (1994) 2.41
Geographically distinct isolates of Mycobacterium leprae exhibit no genotypic diversity by restriction fragment-length polymorphism analysis. Mol Microbiol (1990) 2.25
Non-tuberculous mycobacteria: patterns of isolation. A multi-country retrospective survey. Int J Tuberc Lung Dis (2004) 2.20
Biologically distinct subtypes of Mycobacterium avium differ in possession of insertion sequence IS901. J Clin Microbiol (1992) 2.18
Reconstructing evolution from eukaryotic small-ribosomal-subunit RNA sequences: calibration of the molecular clock. J Mol Evol (1993) 2.11
Results of a standardised regimen for multidrug-resistant tuberculosis in Bangladesh. Int J Tuberc Lung Dis (2004) 2.08
Pulmonary tuberculosis in prisons of the ex-USSR state Georgia: results of a nation-wide prevalence survey among sentenced inmates. Int J Tuberc Lung Dis (2000) 2.01
Detection and identification of mycobacteria by DNA amplification and oligonucleotide-specific capture plate hybridization. J Clin Microbiol (1995) 1.94
Sequence analysis of a highly divergent HIV-1-related lentivirus isolated from a wild captured chimpanzee. Virology (1996) 1.91
Evaluation of mycobacteria growth indicator tube for direct and indirect drug susceptibility testing of Mycobacterium tuberculosis from respiratory specimens in a Siberian prison hospital. J Clin Microbiol (2001) 1.85
Rapid identification of Mycobacteria to the species level using INNO-LiPA Mycobacteria, a reverse hybridization assay. J Clin Microbiol (2001) 1.85
Effects of decontamination methods and culture conditions on viability of Mycobacterium ulcerans in the BACTEC system. J Clin Microbiol (1998) 1.85
Comparison of two PCRs for detection of Mycobacterium ulcerans. J Clin Microbiol (1999) 1.82
Detection of human immunodeficiency virus type 1 (HIV-1) in heel prick blood on filter paper from children born to HIV-1-seropositive mothers. J Clin Microbiol (1994) 1.81
In vitro susceptibility of Mycobacterium ulcerans to clarithromycin. Antimicrob Agents Chemother (1998) 1.80
The development of specific rRNA-derived oligonucleotide probes for Haemophilus ducreyi, the causative agent of chancroid. J Gen Microbiol (1991) 1.77
Multidrug-resistant tuberculosis in prison inmates, Azerbaijan. Emerg Infect Dis (2001) 1.75
[Epidemiology of ulcers due to Mycobacterium ulcerans]. Ann Soc Belg Med Trop (1989) 1.74
Polyclonal emergence and importation of community-acquired methicillin-resistant Staphylococcus aureus strains harbouring Panton-Valentine leucocidin genes in Belgium. J Antimicrob Chemother (2005) 1.70
Relationship between pyrazinamide resistance, loss of pyrazinamidase activity, and mutations in the pncA locus in multidrug-resistant clinical isolates of Mycobacterium tuberculosis. Antimicrob Agents Chemother (1999) 1.69
Direct detection of Brucella spp. in raw milk by PCR and reverse hybridization with 16S-23S rRNA spacer probes. Appl Environ Microbiol (1996) 1.67
Characterization of an unusual Mycobacterium: a possible missing link between Mycobacterium marinum and Mycobacterium ulcerans. J Clin Microbiol (2002) 1.67
Mycobacterium ulcerans infection (Buruli ulcer): first reported patients in Togo. Br J Dermatol (1996) 1.67
Evaluation of Mycobacteria Growth Indicator Tube (MGIT) for drug susceptibility testing of Mycobacterium tuberculosis. Int J Tuberc Lung Dis (1999) 1.63
[Buruli ulcer: risk of bone involvement! Apropos of 33 cases observed in Benin]. Med Trop (Mars) (2000) 1.63
Results of a national survey on drug resistance among pulmonary tuberculosis patients in Rwanda. Int J Tuberc Lung Dis (2007) 1.62
Simple procedure for drug susceptibility testing of Mycobacterium tuberculosis using a commercial colorimetic assay. Eur J Clin Microbiol Infect Dis (1999) 1.59
The use of IS2404 restriction fragment length polymorphisms suggests the diversity of Mycobacterium ulcerans from different geographical areas. Am J Trop Med Hyg (2001) 1.54
Evaluation of tuberculosis control by periodic or routine susceptibility testing in previously treated cases. Int J Tuberc Lung Dis (2001) 1.53
Database on the structure of small ribosomal subunit RNA. Nucleic Acids Res (1998) 1.50
Protective efficacy of a DNA vaccine encoding antigen 85A from Mycobacterium bovis BCG against Buruli ulcer. Infect Immun (2001) 1.50
In vitro activity of ciprofloxacin, sparfloxacin, ofloxacin, amikacin and rifampicin against Ghanaian isolates of Mycobacterium ulcerans. J Antimicrob Chemother (2000) 1.50
Evaluation of PCR-restriction profile analysis and IS2404 restriction fragment length polymorphism and amplified fragment length polymorphism fingerprinting for identification and typing of Mycobacterium ulcerans and M. marinum. J Clin Microbiol (2001) 1.49
Development of a PCR-based line probe assay for identification of fungal pathogens. J Clin Microbiol (2000) 1.48
Mycobacterium ulcerans disease: role of age and gender in incidence and morbidity. Trop Med Int Health (2004) 1.48
Characterization of the virulence of Mycobacterium avium complex (MAC) isolates in mice. Clin Exp Immunol (1994) 1.47
[Mycobacterium ulcerans cutaneous infections: Buruli ulcers]. Med Trop (Mars) (1995) 1.44
Multicenter study of MTT and resazurin assays for testing susceptibility to first-line anti-tuberculosis drugs. Int J Tuberc Lung Dis (2005) 1.43
Kanamycin susceptibility testing of Mycobacterium tuberculosis using Mycobacterium Growth Indicator Tube and a colorimetric method. Antimicrob Agents Chemother (2001) 1.40
Studies on Mycobacterium chelonei. J Med Microbiol (1972) 1.40
Fatty and mycolic acids of Mycobacterium malmoense. J Clin Microbiol (1988) 1.40
Further studies on African strains of Mycobacterium tuberculosis: comparison with M. bovis and M. microti. Ann Soc Belges Med Trop Parasitol Mycol (1970) 1.38
Rhodococcus equi infection in 3 AIDS patients. Acta Clin Belg (1996) 1.38
Limitations and requirements for quality control of sputum smear microscopy for acid-fast bacilli. Int J Tuberc Lung Dis (1998) 1.32
Design and evaluation of new, highly sensitive and specific primers for polymerase chain reaction detection of HIV-1 infected primary lymphocytes. Mol Cell Probes (1994) 1.32
First molecular epidemiological study of tuberculosis in Benin. Int J Tuberc Lung Dis (2009) 1.28
Anti-tuberculosis drug resistance among new and previously treated pulmonary tuberculosis patients in Cotonou, Benin. Int J Tuberc Lung Dis (2007) 1.27
Database on the structure of small subunit ribosomal RNA. Nucleic Acids Res (1999) 1.26
Evaluation of amplified fragment length polymorphism analysis for inter- and intraspecific differentiation of Mycobacterium bovis, M. tuberculosis, and M. ulcerans. J Clin Microbiol (2000) 1.26
Drug resistance monitoring: combined rates may be the best indicator of programme performance. Int J Tuberc Lung Dis (2004) 1.24
Bleach sedimentation method for increased sensitivity of sputum smear microscopy: does it work? Int J Tuberc Lung Dis (2000) 1.20
First reported case of Mycobacterium ulcerans infection in a patient from China. Trans R Soc Trop Med Hyg (2000) 1.19
Impact of short-course therapy on tuberculosis drug resistance in South-West Burkina Faso. Tuber Lung Dis (1996) 1.19
Evaluation of a commercial line probe assay for identification of mycobacterium species from liquid and solid culture. Eur J Clin Microbiol Infect Dis (2002) 1.15
Evaluation of the Genotype® MTBDRplus assay as a tool for drug resistance surveys. Int J Tuberc Lung Dis (2011) 1.15
Growth of mycobacteria in relation to the pH of the medium. Ann Microbiol (Paris) (1983) 1.14
Mycolic acid patterns of four vaccine strains of Mycobacterium bovis BCG. J Gen Microbiol (1983) 1.14
[Traditional treatment for Buruli ulcer in Benin]. Med Trop (Mars) (2004) 1.13
The local immune response in ulcerative lesions of Buruli disease. Clin Exp Immunol (2006) 1.13
Effect of oxygen on growth of Mycobacterium ulcerans in the BACTEC system. J Clin Microbiol (1998) 1.12
Use of a multiplex real-time PCR to study the incidence of human metapneumovirus and human respiratory syncytial virus infections during two winter seasons in a Belgian paediatric hospital. Clin Microbiol Infect (2007) 1.11
A cooperative taxonomic study of mycobacteria isolated from armadillos infected with Mycobacterium leprae. J Gen Microbiol (1986) 1.09
Epidemiological and genetic markers, virulence factors and intracellular growth of Mycobacterium avium in AIDS. Res Microbiol (1992) 1.09